{"id":5048,"date":"2026-11-17T15:18:15","date_gmt":"2026-11-17T13:18:15","guid":{"rendered":"https:\/\/iasispharma.com\/?p=5048"},"modified":"2026-11-17T15:21:27","modified_gmt":"2026-11-17T13:21:27","slug":"iasis-pharma-participation-in-the-4th-international-congress-of-the-hellenic-society-of-dermatology-and-venereology","status":"publish","type":"post","link":"https:\/\/iasispharma.com\/en\/all-articles\/iasis-pharma-participation-in-the-4th-international-congress-of-the-hellenic-society-of-dermatology-and-venereology\/","title":{"rendered":"IASIS PHARMA PARTICIPATION in the &#8220;4th INTERNATIONAL CONGRESS OF THE HELLENIC SOCIETY OF DERMATOLOGY AND VENEREOLOGY&#8221;"},"content":{"rendered":"<p><strong>10 \u2013 15\/11\/2026,<\/strong><\/p>\n<p><strong>Vellidio Convention Center, Thessaloniki.<\/strong><\/p>\n<p><strong>IASIS PHARMA<\/strong> actively participated in the <strong>4th International Congress of the Hellenic Society of Dermatology and Venereology<\/strong> (HSDV), co-organized with the Cypriot Society of Dermatology and Venereology, which took place from <strong>Tuesday, November 10<\/strong> to <strong>Sunday, November 15, 2026<\/strong>, at the Vellidio Convention Center in <strong>Thessaloniki<\/strong>.<\/p>\n<p>In the context of continuous education and the enhancement of clinical strategies, the multifaceted scientific program of the congress provided the opportunity for participating physicians to be informed about new treatments, innovative technologies, and modern scientific data. Through specialized workshops and interactive sessions, modern therapeutic approaches were analyzed and answers were sought to the challenges of daily clinical practice, aiming to translate knowledge into substantial benefits for patients.<\/p>\n<p>During the congress, <strong>IASIS PHARMA <\/strong>participated in a specially designed exhibition stand, where healthcare professionals had the opportunity to visit and be informed about its range of <strong>high-quality pharmaceutical products<\/strong>, with an emphasis on the following products:<\/p>\n<ul>\n<li><strong>Isotroin<b><sup>\u00ae<\/sup><\/b> \/ Isotretinoin: <\/strong>This well-established formulation has been enriched with the new and unique 30mg strength, which complements the existing range of dosages (10mg, 20mg &amp; 40mg). Isotroin\u00ae is indicated for <strong>severe forms of acne resistant to systemic antibiotics and topical therapy<\/strong>.<\/li>\n<li><strong>Combi<b><sup>\u00ae<\/sup><\/b>: <\/strong>A combination of fluprednidene (1mg) + miconazole (20mg) in cream form (50gr), indicated for <strong>Inflammatory Dermatomycoses<\/strong>.<\/li>\n<li><strong>Modiwart<b><sup>\u00ae<\/sup><\/b> \/ Imiquimod (12,5mg\/sachet): <\/strong>An innovative immunomodulator indicated for <strong>External Genital Warts<\/strong>, <strong>Superficial Basal Cell Carcinomas<\/strong>, and <strong>Actinic Keratoses<\/strong>.<\/li>\n<li><strong>Mastiha var. Chia Cutaneous Regenerative Gel: <\/strong>Since 2015, <strong>Chios Mastic<\/strong> has been officially recognized by the <strong>European Medicines Agency (EMA)<\/strong> as an <strong>Herbal Medicinal Product<\/strong>, with the indication: <strong>Skin Inflammations &amp; Healing of Minor Skin Wounds<\/strong> (cutaneous use). It is used for <strong>minor skin inflammations<\/strong> and as an <strong>aid in healing minor wounds<\/strong>. <em>(<u>Concentration<\/u>: Each ml of gel contains 10% lyophilized resin of natural Chios mastic Pistacia lentiscus, excipients. <\/em><em>30ml packaging).<\/em><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><img decoding=\"async\" class=\"alignleft size-full wp-image-5043\" src=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2026\/11\/\u0394\u0399\u0395\u0398\u039d\u0395\u03a3-\u0395\u0394\u0391\u0395-2026_stand-copy.png\" alt=\"\" width=\"800\" height=\"625\" srcset=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2026\/11\/\u0394\u0399\u0395\u0398\u039d\u0395\u03a3-\u0395\u0394\u0391\u0395-2026_stand-copy-200x156.png 200w, https:\/\/iasispharma.com\/wp-content\/uploads\/2026\/11\/\u0394\u0399\u0395\u0398\u039d\u0395\u03a3-\u0395\u0394\u0391\u0395-2026_stand-copy-300x234.png 300w, https:\/\/iasispharma.com\/wp-content\/uploads\/2026\/11\/\u0394\u0399\u0395\u0398\u039d\u0395\u03a3-\u0395\u0394\u0391\u0395-2026_stand-copy-400x313.png 400w, https:\/\/iasispharma.com\/wp-content\/uploads\/2026\/11\/\u0394\u0399\u0395\u0398\u039d\u0395\u03a3-\u0395\u0394\u0391\u0395-2026_stand-copy-500x391.png 500w, https:\/\/iasispharma.com\/wp-content\/uploads\/2026\/11\/\u0394\u0399\u0395\u0398\u039d\u0395\u03a3-\u0395\u0394\u0391\u0395-2026_stand-copy-600x469.png 600w, https:\/\/iasispharma.com\/wp-content\/uploads\/2026\/11\/\u0394\u0399\u0395\u0398\u039d\u0395\u03a3-\u0395\u0394\u0391\u0395-2026_stand-copy-700x547.png 700w, https:\/\/iasispharma.com\/wp-content\/uploads\/2026\/11\/\u0394\u0399\u0395\u0398\u039d\u0395\u03a3-\u0395\u0394\u0391\u0395-2026_stand-copy-768x600.png 768w, https:\/\/iasispharma.com\/wp-content\/uploads\/2026\/11\/\u0394\u0399\u0395\u0398\u039d\u0395\u03a3-\u0395\u0394\u0391\u0395-2026_stand-copy.png 800w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>10 \u2013 15\/11\/2026, Vellidio Convention Center, Thessaloniki. IASIS PHARMA actively participated in the 4th International Congress of the Hellenic Society of Dermatology and Venereology (HSDV), co-organized with the Cypriot Society of Dermatology and Venereology, which took place from Tuesday, November 10 to Sunday, November 15, 2026, at the Vellidio Convention Center in Thessaloniki. In the  [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[33,157,204],"tags":[],"class_list":["post-5048","post","type-post","status-publish","format-standard","hentry","category-all-articles","category-press-room-en","category-conferences"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7HJeP-1jq","jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/5048","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/comments?post=5048"}],"version-history":[{"count":4,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/5048\/revisions"}],"predecessor-version":[{"id":5052,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/5048\/revisions\/5052"}],"wp:attachment":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/media?parent=5048"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/categories?post=5048"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/tags?post=5048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}